Fast-expanding CRO genae is buying into clinical trial technology, acquiring a company that focuses on electronic data capture.
 |
| genae CEO Bart Segers |
The Belgian company paid an undisclosed sum for e-novex, provider of a proprietary technology for gathering trial data and allowing investigators to access it from anywhere. The company's principal offering is e-capture.net, a tool that puts all the forms, queries and questions involved in clinical trials in one place. E-novex also markets the complementary edc2go, designed to speed up the process of generating case report forms from clinical trial sites.
Genae plans to roll e-novex's technology and entire staff into its existing e-Solutions business, which offers data management and statistical services.
"The purchase of e-novex further increases genae's capacity to provide electronic solutions to our customers in the medical industries," CEO Bart Segers said in a statement. "The acquisition is also expected to result in greater eHealth efficiencies and in significantly increasing our capabilities in data management and risk based monitoring."
The Antwerp-headquartered CRO has been steadily expanding its global reach over the past few years, opening outposts in Germany, Switzerland, the U.K. and the U.S.
- read the statement